@article{article, title  = {{Phase I/II open label nonrandomized safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 immunotherapy in combination with PD-1 checkpoint blockade in intermediate-risk localized or locally advanced prostate cancer and advanced metastatic prostate cancer.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{}},

 year = {{2020}},

 month = {{5}},

 author = {{Tuthill M and Cappuccini F and Bryant RJ and Poulton I and Pollock E and Carter L and Verrill C and Meier A and Schmidt G and Catto JWF and Evans T et al}},

 doi = {{10.1200/jco.2020.38.15_suppl.tps3170}},

 volume = {{38}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{15_suppl}},

 pages = {{TPS3170-TPS3170}},

 note = {{Accessed on 2024/12/29}}}